Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $667.52 | 27 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| HARMONY BIOSCIENCES LLC | $179.21 | 1 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $114.82 | 4 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $84.36 | 4 | $0 (2020) |
| Lundbeck LLC | $81.33 | 4 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $53.43 | 5 | $0 (2019) |
| Neurocrine Biosciences, Inc. | $42.93 | 2 | $0 (2019) |
| Allergan Inc. | $34.73 | 2 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $31.92 | 2 | $0 (2020) |
| Avanir Pharmaceuticals, Inc. | $17.71 | 1 | $0 (2019) |
| Bausch Health US, LLC | $14.05 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $179.21 | 1 | HARMONY BIOSCIENCES LLC ($179.21) |
| 2020 | $171.90 | 8 | Vanda Pharmaceuticals Inc. ($59.57) |
| 2019 | $316.41 | 18 | Vanda Pharmaceuticals Inc. ($55.25) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/23/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $179.21 | General |
| Category: Narcoplepsy | ||||||
| 03/20/2020 | Bausch Health US, LLC | WELLBUTRIN (Drug), APLENZIN | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: NEUROLOGY | ||||||
| 03/11/2020 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.88 | General |
| Category: PSYCHIATRY | ||||||
| 03/05/2020 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $30.51 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 02/27/2020 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Neuroscience | ||||||
| 02/11/2020 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: NEUROSCIENCE | ||||||
| 01/30/2020 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2020 | Lundbeck LLC | BRINTELLIX (Drug) | Food and Beverage | Cash or cash equivalent | $20.35 | General |
| Category: PSYCHIATRY | ||||||
| 01/16/2020 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $29.06 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/09/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: CNS | ||||||
| 12/05/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: CNS | ||||||
| 11/07/2019 | Vanda Pharmaceuticals Inc. | Fanapt (Drug), Hetlioz | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: Schizophrenia | ||||||
| 11/05/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Vyvanse (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Central Nervous System (CNS) | ||||||
| 10/24/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $4.86 | General |
| Category: CNS | ||||||
| 10/21/2019 | Lundbeck LLC | BRINTELLIX (Drug) | Food and Beverage | Cash or cash equivalent | $21.55 | General |
| Category: PSYCHIATRY | ||||||
| 09/26/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $6.87 | General |
| Category: CNS | ||||||
| 09/16/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: CNS | ||||||
| 08/27/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Vyvanse (Drug) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: Central Nervous System (CNS) | ||||||
| 07/15/2019 | Vanda Pharmaceuticals Inc. | Fanapt (Drug), Hetlioz | Food and Beverage | In-kind items and services | $28.63 | General |
| Category: Schizophrenia | ||||||
| 07/11/2019 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 07/01/2019 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: NEUROLOGY | ||||||
| 06/13/2019 | Ironshore Pharmaceuticals Inc. | Jornay PM 20mg capsules (Bottle of 100) (Drug) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: Central nervous system (CNS) stimulant | ||||||
| 06/06/2019 | Lundbeck LLC | BRINTELLIX (Drug) | Food and Beverage | Cash or cash equivalent | $21.55 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 29 | 72 | $19,295 | $6,335 |
| 2021 | 2 | 59 | 127 | $21,920 | $12,618 |
| 2020 | 2 | 28 | 41 | $7,740 | $3,836 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 72 | $19,295 | $6,335 | 32.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 34 | 102 | $15,400 | $9,569 | 62.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 25 | 25 | $6,520 | $3,049 | 46.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 15 | 28 | $4,360 | $2,225 | 51.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 13 | 13 | $3,380 | $1,610 | 47.6% |
About Dr. Simone Litsch, M.D
Dr. Simone Litsch, M.D is a Psychiatry healthcare provider based in Newport Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1598882599.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Simone Litsch, M.D has received a total of $667.52 in payments from pharmaceutical and medical device companies, with $179.21 received in 2024. These payments were reported across 27 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($667.52).
As a Medicare-enrolled provider, Litsch has provided services to 116 Medicare beneficiaries, totaling 240 services with total Medicare billing of $22,788. Data is available for 3 years (2020–2022), covering 5 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Other Specialties Sleep Medicine, Sleep Medicine
- Location Newport Beach, CA
- Active Since 03/23/2007
- Last Updated 04/25/2019
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1598882599
Products in Payments
- WAKIX (Drug) $179.21
- BRINTELLIX (Drug) $63.45
- HETLIOZ (Drug) $59.57
- Fanapt (Drug) $55.25
- LATUDA (Drug) $53.43
- INGREZZA (Drug) $42.93
- Vyvanse (Drug) $41.31
- VRAYLAR (Drug) $34.73
- VYVANSE (Drug) $23.09
- TRINTELLIX (Drug) $19.96
- REXULTI (Drug) $17.88
- NUEDEXTA (Drug) $17.71
- INVEGA SUSTENNA (Drug) $17.00
- SPRAVATO (Drug) $14.92
- WELLBUTRIN (Drug) $14.05
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $13.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Newport Beach
Dr. Nader Oskooilar, Md, MD
Psychiatry — Payments: $321,179
Dr. Hadi Estakhri, M.d, M.D
Psychiatry — Payments: $16,721
Dr. Venice Sanchez, M.d, M.D
Psychiatry — Payments: $16,294
Dr. Hisham Korraa, M.d, M.D
Psychiatry — Payments: $14,252
Dr. Stefani Lafrenierre, Md, MD
Psychiatry — Payments: $7,842
Nimisha Jain, Pa, PA
Psychiatry — Payments: $6,289